Evidence map›Paper›PMID 35968193›Full record

ArticleThe journal of physical chemistry. C, Nanomaterials and interfaces2022

Extreme-Ultraviolet Excited Scintillation of Methylammonium Lead Bromide Perovskites.

Maarten L S van der Geest, Lucie McGovern, Stefan van Vliet, Hanya Y Zwaan, Gianluca Grimaldi, Jeroen de Boer, Roland Bliem, Bruno Ehrler, Peter M Kraus

Open access · hybridAbstract read
In one paragraph

Article in The journal of physical chemistry. C, Nanomaterials and interfaces, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Maarten L S van der GeestAdvanced Research Center for Nanolithography, Science Park 106, 1098 XG Amsterdam, The Netherlands.
Lucie McGovernCenter for Nanophotonics, AMOLF, Science Park 102, 1098 XG Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-7263-5249
Stefan van VlietAdvanced Research Center for Nanolithography, Science Park 106, 1098 XG Amsterdam, The Netherlands.
Hanya Y ZwaanAdvanced Research Center for Nanolithography, Science Park 106, 1098 XG Amsterdam, The Netherlands.
Gianluca GrimaldiCenter for Nanophotonics, AMOLF, Science Park 102, 1098 XG Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-2626-9118
Jeroen de BoerCenter for Nanophotonics, AMOLF, Science Park 102, 1098 XG Amsterdam, The Netherlands.
Roland BliemAdvanced Research Center for Nanolithography, Science Park 106, 1098 XG Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-8714-8942
Bruno EhrlerCenter for Nanophotonics, AMOLF, Science Park 102, 1098 XG Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-5307-3241
Peter M KrausAdvanced Research Center for Nanolithography, Science Park 106, 1098 XG Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-2989-5560
Advanced Research Center for Nanolithography (Netherlands) · NLInstitute for Atomic and Molecular Physics · NLUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inorganic-Organic lead halide materials have been recognized as potential high-energy X-ray detectors because of their high quantum efficiencies and radiation hardness. Surprisingly little is known about whether the same is true for extreme-ultraviolet (XUV) radiation, despite applications in nuclear fusion research and astrophysics. We used a table-top high-harmonic generation setup in the XUV range between 20 and 45 eV to photoexcite methylammonium lead bromide (MAPbBr

Identifiers

PMID35968193
PMCPMC9358647
OpenAlexW4286498612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.